SCHEMBL22285879

SCHEMBL22285879

CCOC(=O)Cn1c(=O)c(=O)n(CC(O)C(O)C(O)CO)c2cc(C)c(C)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.44
▸ ALDH1A1 P00352 5/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ USP2 O75604 2/20 0.44
▸ CASP1 P29466 2/20 0.44
▸ BRCA1 P38398 2/20 0.44
▸ RECQL P46063 2/20 0.44
▸ CASP7 P55210 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ HBB P68871 1/20 0.44
▸ HAT1 O14929 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19411274 1.00 KDM4E (0.44) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL19411265 0.83 TDP1 (0.50) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL22285880 0.83 TDP1 (0.50) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL22285881 0.78 TDP1 (0.43) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL22285876 0.77 KMT2A (0.47) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL19411266 0.77 KMT2A (0.47) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL22285882 0.77 TDP1 (0.47) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL19411259 0.77 TDP1 (0.47) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL22071680 0.77 MEN1 (0.55) KDM4EALDH1A1MEN1KMT2AUSP2
SCHEMBL22071669 0.77 MEN1 (0.55) KDM4EALDH1A1MEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11002524-B2 Cyclic compounds and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2021-05-11 — — US claimed
US-20200249002-A9 A CYCLIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-08-06 — — US claimed
US-11002524-B2 Cyclic compounds and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2021-05-11 — — US disclosed
US-20200249002-A9 A CYCLIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11002524-B2 Cyclic compounds and process for the preparation thereof VIP, TREH, CCKAR KDM4E 3109/4885ALDH1A1 2806/4885MEN1 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback